Meta-Flux

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

1. HiringBetween 3 September 2025 and 6 November 2026

   Added a careers page.

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagecurrent websiteHistorical capture not publicly availableLink to observation
2. HeadlineBetween 3 September 2025 and 6 November 2026

   BeforeUNLEASH YOUR DATA

   AfterBuilding the intelligence layer to simulate disease. disease.

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagecurrent websiteHistorical capture not publicly availableLink to observation
3. HeadlineBetween 29 September 2023 and 13 December 2024

   BeforeAccelerating Lung Cancer treatments

   AfterUNLEASH YOUR DATA

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagelater archived pageLink to observation

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

1. Seen November 2026 · 1 capture · latest observed messagingBuilding the intelligence layer to simulate disease. disease.

   Meta-Flux is building the intelligence layer to simulate disease — high-fidelity in-silico models that let researchers run experiments across oncology, neurodegeneration, and immuno-oncology.

   This wording observed 6 November 2026.

   current websiteHistorical capture not publicly available
2. December 2024 – September 2025 · 2 capturesUNLEASH YOUR DATA

   AI Biologist providing adaptive experimentation through multi-omic data

   This wording observed 3 September 2025.

   archived page
   Inspect 2 captures in this group

   • 13 December 2024 · UNLEASH YOUR DATA archived page
   • 3 September 2025 · UNLEASH YOUR DATA archived page
3. Seen September 2023 · 1 captureAccelerating Lung Cancer treatments

   Discover Meta-flux an innovative Biotech startup from Dublin currently developing powerful predictive algorithms using metabolomic data to identify diseases

   This wording observed 29 September 2023.

   archived page

Companies in the same space

Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.

• CytoReason cytoreason.comDirect competitorBoth build AI-driven computational disease models to support biopharma drug discovery and development decisions.
• CellType celltype.comDirect competitorBoth offer AI platforms that simulate human biology to guide target selection and drug development for pharma and biotech R&D.
• GNS Healthcare gnshealthcare.comDirect competitorBoth provide causal AI and simulation platforms using multi-omics data for precision medicine and drug discovery/development.
• VeriSIM Life verisimlife.comPartial overlapBoth use AI-enabled biosimulation to predict drug effects, though one focuses more on clinical outcome prediction.
• Valinor Biotechnologies valinorbio.aiPartial overlapBoth use AI and multi-omics disease models, but one targets clinical development and patient selection rather than preclinical R&D.